511 related articles for article (PubMed ID: 33128665)
1. Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis.
Udomsinprasert W; Jittikoon J; Sangroongruangsri S; Chaikledkaew U
J Clin Immunol; 2021 Jan; 41(1):11-22. PubMed ID: 33128665
[TBL] [Abstract][Full Text] [Related]
2. Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.
Wang J; Yang X; Li Y; Huang JA; Jiang J; Su N
Virol J; 2021 Jun; 18(1):117. PubMed ID: 34088317
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis.
Mulchandani R; Lyngdoh T; Kakkar AK
Eur J Clin Invest; 2021 Jan; 51(1):e13429. PubMed ID: 33058143
[TBL] [Abstract][Full Text] [Related]
4. Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients.
Mortaz E; Tabarsi P; Jamaati H; Dalil Roofchayee N; Dezfuli NK; Hashemian SM; Moniri A; Marjani M; Malekmohammad M; Mansouri D; Varahram M; Folkerts G; Adcock IM
Front Immunol; 2021; 12():592727. PubMed ID: 33968010
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
Azar MM; Shin JJ; Kang I; Landry M
Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
[TBL] [Abstract][Full Text] [Related]
6. Laboratory biomarkers associated with COVID-19 severity and management.
Keddie S; Ziff O; Chou MKL; Taylor RL; Heslegrave A; Garr E; Lakdawala N; Church A; Ludwig D; Manson J; Scully M; Nastouli E; Chapman MD; Hart M; Lunn MP
Clin Immunol; 2020 Dec; 221():108614. PubMed ID: 33153974
[TBL] [Abstract][Full Text] [Related]
7. Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19.
Vassiliou AG; Dimopoulou I; Jahaj E; Keskinidou C; Mastora Z; Orfanos SE; Kotanidou A
In Vivo; 2021; 35(2):1295-1298. PubMed ID: 33622933
[TBL] [Abstract][Full Text] [Related]
8. Serum IL-6: A potential biomarker of mortality among SARS-CoV-2 infected patients in Mexico.
Avila-Nava A; Cortes-Telles A; Torres-Erazo D; López-Romero S; Chim Aké R; Gutiérrez Solis AL
Cytokine; 2021 Jul; 143():155543. PubMed ID: 33896708
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: A living systematic review and meta-analysis.
Melo AKG; Milby KM; Caparroz ALMA; Pinto ACPN; Santos RRP; Rocha AP; Ferreira GA; Souza VA; Valadares LDA; Vieira RMRA; Pileggi GS; Trevisani VFM
PLoS One; 2021; 16(6):e0253894. PubMed ID: 34185801
[TBL] [Abstract][Full Text] [Related]
10. Cytokine profiling in Iranian patients with COVID-19; association with clinical severity.
Taghiloo S; Soltanshahi M; Aliyali M; Abedi S; Mehravaran H; Ajami A; Asgarian-Omran H
Iran J Immunol; 2021 Mar; 18(1):54-64. PubMed ID: 33787514
[TBL] [Abstract][Full Text] [Related]
11. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
Han H; Ma Q; Li C; Liu R; Zhao L; Wang W; Zhang P; Liu X; Gao G; Liu F; Jiang Y; Cheng X; Zhu C; Xia Y
Emerg Microbes Infect; 2020 Dec; 9(1):1123-1130. PubMed ID: 32475230
[TBL] [Abstract][Full Text] [Related]
12. Elevated Levels of Pleiotropic Interleukin-6 (IL-6) and Interleukin-10 (IL-10) are Critically Involved With the Severity and Mortality of COVID-19: An Updated Longitudinal Meta-Analysis and Systematic Review on 147 Studies.
Jafrin S; Aziz MA; Islam MS
Biomark Insights; 2022; 17():11772719221106600. PubMed ID: 35747885
[TBL] [Abstract][Full Text] [Related]
13. Multiplex Immunoassay for Prediction of Disease Severity Associated with the Cytokine Storm in COVID-19 Cases.
Guest PC; Abbasifard M; Jamialahmadi T; Majeed M; Kesharwani P; Sahebkar A
Methods Mol Biol; 2022; 2511():245-256. PubMed ID: 35838965
[TBL] [Abstract][Full Text] [Related]
14. Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality.
Moradian N; Gouravani M; Salehi MA; Heidari A; Shafeghat M; Hamblin MR; Rezaei N
Eur Cytokine Netw; 2020 Sep; 31(3):81-93. PubMed ID: 33361013
[TBL] [Abstract][Full Text] [Related]
15. Elevated interleukin levels are associated with higher severity and mortality in COVID 19 - A systematic review, meta-analysis, and meta-regression.
Yonas E; Alwi I; Pranata R; Huang I; Lim MA; Yamin M; Nasution SA; Setiati S; Virani SS
Diabetes Metab Syndr; 2020; 14(6):2219-2230. PubMed ID: 33395783
[TBL] [Abstract][Full Text] [Related]
16. Impacts of Inflammatory Cytokines Variants on Systemic Inflammatory Profile and COVID-19 Severity.
Deng X; Tang K; Wang Z; He S; Luo Z
J Epidemiol Glob Health; 2024 Jun; 14(2):363-378. PubMed ID: 38376765
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia.
Santa Cruz A; Mendes-Frias A; Oliveira AI; Dias L; Matos AR; Carvalho A; Capela C; Pedrosa J; Castro AG; Silvestre R
Front Immunol; 2021; 12():613422. PubMed ID: 33679753
[TBL] [Abstract][Full Text] [Related]
18. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality.
Alosaimi B; Mubarak A; Hamed ME; Almutairi AZ; Alrashed AA; AlJuryyan A; Enani M; Alenzi FQ; Alturaiki W
Front Immunol; 2021; 12():668725. PubMed ID: 34276659
[TBL] [Abstract][Full Text] [Related]
19. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
Bozorgmehr N; Mashhouri S; Perez Rosero E; Xu L; Shahbaz S; Sligl W; Osman M; Kutsogiannis DJ; MacIntyre E; O'Neil CR; Elahi S
mBio; 2021 May; 12(3):. PubMed ID: 33947753
[TBL] [Abstract][Full Text] [Related]
20. The Role of Inflammatory Cytokines (Interleukin-1 and Interleukin-6) as a Potential Biomarker in the Different Stages of COVID-19 (Mild, Severe, and Critical).
Ghofrani Nezhad M; Jami G; Kooshkaki O; Chamani S; Naghizadeh A
J Interferon Cytokine Res; 2023 Apr; 43(4):147-163. PubMed ID: 37062817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
